Corporate Support ISAL XX 2027
The organizers of ACUTE LEUKEMIAS XX (ISALXX) wish to thank all corporate partners to actively for their support of the international symposium ACUTE LEUKEMIAS XX, Munich, March 14-17, 2027.
The organizers highly value the partnerships and their important role that members of this community play by supporting the international symposium ACUTE LEUKEMIAS in their effort to provide hematologists with high quality educational sessions thus rendering all attendees the opportunity to discuss the most recent findings in basic research and results of clinical studies on the field of acute leukemias.
| Abbvie Deutschland GmbH | ||
![]() |
Amgen GmbH | |
![]() |
Astellas Pharma GmbH | |
| Daiichi Sankyo GmbH | ||
| Jazz Pharmaceuticals | ||
| Neovii Biotech GmbN | ||
![]() |
Otsuka Pharma GmbH | |
![]() |
Servier Deutschland GmbH | |
![]() |
Servier France |




